Morning Overview on MSN
A Harvard scientist says his team is preparing the first human trials aimed at reversing aging
A team linked to Harvard Medical School has dosed the first patient in a clinical trial designed to reverse cellular aging in ...
In a breakthrough for longevity science, a reverse-aging treatment has been injected into a human. The technique is a sought-after solution for improving longevity by reprogramming cells. Competitors ...
Promising mouse studies and billions of dollars in funding are stoking excitement. But we’ve been here before.
Life Biosciences says it just dosed its first patient in an FDA-approved clinical trial to reverse age-related blindness.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results